santé – Essais cliniques menés pendant le covid-19 par l'IHU Méditerranée

This written question concerns clinical trials conducted by the IHU Méditerranée during the COVID-19 pandemic in France. It seeks clarification on the procedures and outcomes of these trials. The question is relevant to public health policy, research ethics, and the management of health crises. It may affect patients, researchers, and healthcare institutions involved in clinical research.